---
title: "Feasibility of cranial electrotherapy stimulation (Alpha-Stim AID) for anxiety with breathlessness"
id: "medrxiv-17-evaluating-cranial-electrotherapy-stimulation-for-anxiety-associated-with"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-evaluating-cranial-electrotherapy-stimulation-for-anxiety-associated-with"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.22.26361094v1?rss=1"
published_at: "2026-08-25T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Feasibility of cranial electrotherapy stimulation (Alpha-Stim AID) for anxiety with breathlessness
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-evaluating-cranial-electrotherapy-stimulation-for-anxiety-associated-with
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.22.26361094v1?rss=1)
- **Published At:** 2026-08-25T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This mixed-methods feasibility study evaluated the acceptability and tolerability of **cranial electrotherapy stimulation (CES)** using the **Alpha-Stim AID** device in adults with advanced chronic respiratory disease receiving hospice care who had clinically significant anxiety and breathlessness. - Design: multicentre, non-randomised interventional feasibility study with a parallel usual-care control group; intervention lasted eight weeks with a four-week follow-up; study not powered for efficacy. - Participants: recruited from hospice services; 12.5% of screened patients at the primary site were eligible, and 29 unique participants enrolled. Three participants (10.3%) withdrew; withdrawals were not attributed to CES. - Intervention arms: participants used Alpha-Stim AID for eight weeks at either a fixed or personalised dose; delivery occurred within hospice services. - Safety and tolerability: most adverse events were mild. Headache was reported commonly across both intervention and control groups. No withdrawals were directly due to CES. - Acceptability and adherence: the device was generally acceptable and deliverable in the hospice setting. Outcome measure completion rates were high, with missing data under 6.4%. - Outcomes: daily numerical rating scales for anxiety and breathlessness fluctuated and were broadly static overall; Generalized Anxiety Disorder-7 (**GAD-7**) scores improved over time across all groups, though this trial was not designed to establish clinical efficacy. - Recommendations and next steps: authors conclude CES with Alpha-Stim AID is feasible in this population and support progression to a fully powered randomized controlled trial against a sham device to determine clinical effectiveness for anxiety in people with breathlessness. - Ethics and registration: Brighton and Sussex NHS Research and Ethics Committee approved the study (ref 23/LO/0276); trial registration NCT06066658; data available from corresponding author on reasonable request. - Funding and disclosures: funders included NIHR, Wellcome Trust, and Stoneygate Trust; authors declared no competing interests.
## Clinical Analysis & Structured Key Points
Evaluating cranial electrotherapy stimulation for anxiety associated with breathlessness in palliative care: a mixed-methods feasibility study | medRxiv Skip to main content Evaluating cranial electrotherapy stimulation for anxiety associated with breathlessness in palliative care: a mixed-methods feasibility study View ORCID Profile Lucy Bleazard , Sarah R Copping , Sarah Booth , Laura J Gray , Christina Faull , Kate Walker , Chris Griffiths , View ORCID Profile David Wenzel doi: https://doi.org/10.64898/2026.08.22.26361094 Lucy Bleazard 1 University of Leicester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Lucy Bleazard For correspondence: lucybleazard{at}loros.co.uk Sarah R Copping 1 University of Leicester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sarah Booth 1 University of Leicester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Laura J Gray 1 University of Leicester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christina Faull 2 LOROS Hospice; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kate Walker 3 Northamptonshire Healthcare NHS Foundation Trust Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chris Griffiths 3 Northamptonshire Healthcare NHS Foundation Trust Find this author on Google Scholar Find this author on PubMed Search for this author on this site David Wenzel 1 University of Leicester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for David Wenzel Abstract Info/History Metrics Data/Code Preview PDF Abstract Objectives To explore the acceptability and tolerability of cranial electrotherapy stimulation (CES) using Alpha-Stim AID as a potential intervention for anxiety associated with breathlessness in people with advanced chronic respiratory disease. Methods A multicentre, mixed-methods, non-randomised interventional feasibility study with a parallel usual-care control group. Participants were adults with chronic respiratory disease and significant anxiety and breathlessness symptoms (assessed via Integrated Palliative Outcome Scale) receiving care from hospice services. The intervention groups used Alpha-Stim AID for eight weeks either at a fixed or personalised dose, followed by a four-week follow-up period. This feasibility study was not powered to assess clinical efficacy. Results 12.5% of screened patients at the primary site were eligible, and 29 unique participants were recruited. Three participants withdrew from the study (10.3%), none of which were attributable to CES. Most adverse events were mild, with headache reported frequently across control and intervention groups. Outcome measure completion was high, with data missingness below 6.4%. Numerical rating scales of anxiety and breathlessness fluctuated daily and remained broadly static, whereas GAD-7 scores assessing anxiety improved over time across all groups. This feasibility study was not powered to assess clinical efficacy. Conclusion CES using Alpha-Stim AID was deliverable within hospice services and was generally acceptable and tolerable among participants who enrolled. Our findings support further evaluation which should involve a fully-powered randomised controlled trial against a sham device to determine whether CES provides clinically meaningful improvements in anxiety for this patient population. Competing Interest Statement The authors have declared no competing interest. Clinical Trial NCT06066658 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Brighton and Sussex NHS Research and Ethics Committee gave ethical approval for this work (reference 23/LO/0276). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data are available from the corresponding author upon reasonable request. The data generated in this study are subject to patient confidentiality, and the transfer of data or materials will require appropriate institutional data protection approval. Funder Information Declared NIHR , EMD/ACA- 094- 001 Wellcome Trust, https://ror.org/029chgv08 , MHN DTP-223508/Z/21/Z Stoneygate Trust , N/A Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted August 25, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Evaluating cranial electrotherapy stimulation for anxiety associated with breathlessness in palliative care: a mixed-methods feasibility study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Evaluating cranial electrotherapy stimulation for anxiety associated with breathlessness in palliative care: a mixed-methods feasibility study Lucy Bleazard , Sarah R Copping , Sarah Booth , Laura J Gray , Christina Faull , Kate Walker , Chris Griffiths , David Wenzel medRxiv 2026.08.22.26361094; doi: https://doi.org/10.64898/2026.08.22.26361094 Share This Article: Copy Citation Tools Evaluating cranial electrotherapy stimulation for anxiety associated with breathlessness in palliative care: a mixed-methods feasibility study Lucy Bleazard , Sarah R Copping , Sarah Booth , Laura J Gray , Christina Faull , Kate Walker , Chris Griffiths , David Wenzel medRxiv 2026.08.22.26361094; doi: https://doi.org/10.64898/2026.08.22.26361094 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (611) Allergy and Immunology (891) Anesthesia (324) Cardiovascular Medicine (4746) Dentistry and Oral Medicine (473) Dermatology (406) Emergency Medicine (639) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1609) Epidemiology (15781) Forensic Medicine (32) Gastroenterology (1193) Genetic and Genomic Medicine (6953) Geriatric Medicine (724) Health Economics (1050) Health Informatics (4952) Health Policy (1420) Health Systems and Quality Improvement (1730) Hematology (577) HIV/AIDS (1327) Infectious Diseases (except HIV/AIDS) (16224) Intensive Care and Critical Care Medicine (1156) Medical Education (659) Medical Ethics (150) Nephrology (717) Neurology (7147) Nursing (360) Nutrition (1071) Obstetrics and Gynecology (1221) Occupational and Environmental Health (996) Oncology (3561) Ophthalmology (1031) Orthopedics (390) Otolaryngology (443) Pain Medicine (464) Palliative Medicine (138) Pathology (702) Pediatrics (1767) Pharmacology and Therapeutics (730) Primary Care Research (757) Psychiatry and Clinical Psychology (5807) Public and Global Health (9652) Radiology and Imaging (2368) Rehabilitation Medicine and Physical Therapy (1422) Respiratory Medicine (1235) Rheumatology (631) Sexual and Reproductive Health (762) Sports Medicine (571) Surgery (758) Toxicology (106) Transplantation (301) Urology (285)
## Related Clinical Research

- [North West London Diabetes Cohort: multiethnic EHR resource for diabetes complications research](https://medichelpline.com/clinical-feed/bmj-open-2-large-scale-multiethnic-electronic-health-record-resource-for-diabetes.md)
- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Pregabalin for Treatment-Resistant Generalised Anxiety Disorder: Statistical Analysis Plan for the](https://medichelpline.com/clinical-feed/medrxiv-16-pregabalin-for-treatment-resistant-generalised-anxiety-disorder-statistical.md)
- [Diurnal and Seasonal Variation in Brain mu-Opioid and Dopamine D2 Receptor Signaling](https://medichelpline.com/clinical-feed/biorxiv-6-diurnal-and-seasonal-regulation-of-brain-mu-opioid-and-dopamine-d2-receptor.md)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.